Our RNA-seq studies using OCa model cells confirmed these earlier observations and showed that ERβ natural agonists suppress cytokine, immune, and metastatic pathways and activate pathways that promote apoptosis. The gene discussed is ESR2; the disease is oculocutaneous albinism.